Work

Minimal residual disease as a prognostic marker in chronic lymphocytic leukemia: A meta-analysis across chemoimmunotherapy and targeted therapies

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417004828
Cites:
Cited by:
Related to: